Treatment of Mycobacterium abscessus Infection

Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Novosad, Shannon A., Beekmann, Susan E., Polgreen, Philip M., Mackey, Kate, Winthrop, Kevin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2016
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766900/
https://www.ncbi.nlm.nih.gov/pubmed/26890211
http://dx.doi.org/10.3201/eid2203.150828
_version_ 1782417749847310336
author Novosad, Shannon A.
Beekmann, Susan E.
Polgreen, Philip M.
Mackey, Kate
Winthrop, Kevin L.
author_facet Novosad, Shannon A.
Beekmann, Susan E.
Polgreen, Philip M.
Mackey, Kate
Winthrop, Kevin L.
author_sort Novosad, Shannon A.
collection PubMed
description Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy.
format Online
Article
Text
id pubmed-4766900
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-47669002016-03-01 Treatment of Mycobacterium abscessus Infection Novosad, Shannon A. Beekmann, Susan E. Polgreen, Philip M. Mackey, Kate Winthrop, Kevin L. Emerg Infect Dis Dispatch Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting effective drugs or dosing regimens are limited. To better identify treatment approaches and associated toxicities, we collected a series of case reports from the Emerging Infections Network. Side effects were common and often led to changing or discontinuing therapy. Centers for Disease Control and Prevention 2016-03 /pmc/articles/PMC4766900/ /pubmed/26890211 http://dx.doi.org/10.3201/eid2203.150828 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Novosad, Shannon A.
Beekmann, Susan E.
Polgreen, Philip M.
Mackey, Kate
Winthrop, Kevin L.
Treatment of Mycobacterium abscessus Infection
title Treatment of Mycobacterium abscessus Infection
title_full Treatment of Mycobacterium abscessus Infection
title_fullStr Treatment of Mycobacterium abscessus Infection
title_full_unstemmed Treatment of Mycobacterium abscessus Infection
title_short Treatment of Mycobacterium abscessus Infection
title_sort treatment of mycobacterium abscessus infection
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766900/
https://www.ncbi.nlm.nih.gov/pubmed/26890211
http://dx.doi.org/10.3201/eid2203.150828
work_keys_str_mv AT novosadshannona treatmentofmycobacteriumabscessusinfection
AT beekmannsusane treatmentofmycobacteriumabscessusinfection
AT polgreenphilipm treatmentofmycobacteriumabscessusinfection
AT mackeykate treatmentofmycobacteriumabscessusinfection
AT winthropkevinl treatmentofmycobacteriumabscessusinfection
AT treatmentofmycobacteriumabscessusinfection

Ejemplares similares